To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Nov 14, 2017)
This bill nullifies a rule finalized by the Centers for Medicare & Medicaid Services on November 13, 2017, that modifies payment under Medicare for certain drugs purchased through the 340B discount program.
What just happenedNov 17, 2017
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseNov 14, 2017
- Nov 17, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Nov 14, 2017IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Nov 14, 2017IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Nov 14, 2017IntroReferralIntro-H
Introduced in House
- Nov 14, 2017IntroReferral1000
Introduced in House